Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Revenue (2016 - 2025)

Lisata Therapeutics' Revenue history spans 11 years, with the latest figure at $100000.0 for Q4 2025.

  • For Q4 2025, Revenue fell 90.0% year-over-year to $100000.0; the TTM value through Dec 2025 reached $170000.0, down 83.0%, while the annual FY2025 figure was $170000.0, 83.0% down from the prior year.
  • Revenue reached $100000.0 in Q4 2025 per LSTA's latest filing, up from $70000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.0 million in Q4 2024 to a low of $70000.0 in Q2 2025.